These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29373898)

  • 1. Anti-ROR1 scFv-EndoG as a Novel Anti-Cancer Therapeutic Drug.
    Bemani P; Mohammadi M; Hakakian A
    Asian Pac J Cancer Prev; 2018 Jan; 19(1):97-102. PubMed ID: 29373898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique.
    Aghebati-Maleki L; Younesi V; Jadidi-Niaragh F; Baradaran B; Majidi J; Yousefi M
    Hum Antibodies; 2017; 25(1-2):57-63. PubMed ID: 28128766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Human Recombinant Antibodies Against ROR1 Tumor Antigen.
    Bemani P; Moazen S; Nadimi E; Nejatollahi F
    Rep Biochem Mol Biol; 2022 Jul; 11(2):282-288. PubMed ID: 36164620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells.
    Yin Z; Gao M; Chu S; Su Y; Ye C; Wang Y; Pan Z; Wang Z; Zhang H; Tong H; Zhu J
    Oncotarget; 2017 Nov; 8(55):94210-94222. PubMed ID: 29212222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel human recombinant antibody fragment capable of neutralizing Mexican scorpion toxins.
    Riaño-Umbarila L; Olamendi-Portugal T; Morelos-Juárez C; Gurrola GB; Possani LD; Becerril B
    Toxicon; 2013 Dec; 76():370-6. PubMed ID: 24067940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
    Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
    Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
    Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
    Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.
    Goyal A; Batra JK
    Biochem J; 2000 Jan; 345 Pt 2(Pt 2):247-54. PubMed ID: 10620501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
    Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of a recombinant anti-monkey anti-CD3 diphtheria toxin based immunotoxin by yeast display affinity maturation of the scFv.
    Wang Z; Kim GB; Woo JH; Liu YY; Mathias A; Stavrou S; Neville DM
    Bioconjug Chem; 2007; 18(3):947-55. PubMed ID: 17352456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A collagen-binding EGFR single-chain Fv antibody fragment for the targeted cancer therapy.
    Liang H; Li X; Chen B; Wang B; Zhao Y; Zhuang Y; Shen H; Zhang Z; Dai J
    J Control Release; 2015 Jul; 209():101-9. PubMed ID: 25916496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.
    Hojjat-Farsangi M; Moshfegh A; Daneshmanesh AH; Khan AS; Mikaelsson E; Osterborg A; Mellstedt H
    Semin Cancer Biol; 2014 Dec; 29():21-31. PubMed ID: 25068995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomic force microscopy study of the antigen-antibody binding force on patient cancer cells based on ROR1 fluorescence recognition.
    Li M; Xiao X; Liu L; Xi N; Wang Y; Dong Z; Zhang W
    J Mol Recognit; 2013 Sep; 26(9):432-8. PubMed ID: 23836471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel cytoprotective inhibitors for apoptotic endonuclease G.
    Jang DS; Penthala NR; Apostolov EO; Wang X; Crooks PA; Basnakian AG
    DNA Cell Biol; 2015 Feb; 34(2):92-100. PubMed ID: 25401220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: influence of affinity, size, and stability.
    Bera TK; Pastan I
    Bioconjug Chem; 1998; 9(6):736-43. PubMed ID: 9815167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a humanized single-chain variable fragment antibody targeting chronic myeloid leukemia cells in Escherichia coli and its characterization.
    Zhu X; Wang D; Li S; Xiao Q; Tao K; Hu J; Cao W; Feng W
    Int J Mol Med; 2012 May; 29(5):939-45. PubMed ID: 22322313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hepatoma human single-chain Fv antibody and adriamycin conjugates with potent antitumor activity.
    Chen L; Liu YH; Li YH; Jiang Y; Xie PL; Zhou GH; Li GC
    Int Immunopharmacol; 2014 Jan; 18(1):20-6. PubMed ID: 24239629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Daneshmanesh AH; Mozaffari F; Moshfegh A; Hansson L; Razavi SM; Sharifian RA; Rabbani H; Österborg A; Mellstedt H; Shokri F
    PLoS One; 2015; 10(11):e0142310. PubMed ID: 26562161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.
    Shabani M; Naseri J; Shokri F
    Expert Opin Ther Targets; 2015 Jul; 19(7):941-55. PubMed ID: 25835638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insilico analysis of three different tag polypeptides with dual roles in scFv antibodies.
    Mohammadi M; Nejatollahi F; Sakhteman A; Zarei N
    J Theor Biol; 2016 Aug; 402():100-6. PubMed ID: 27113782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.